Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Acute kidney injury and fluid balance

Paediatrics and child health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Hyperkalaemia, pulmonary oedema or anuria

ECG change, severe potassium elevation, pulmonary oedema, refractory acidosis, uraemic encephalopathy or pericarditis, anuria and rapidly increasing fluid overload can become fatal before the cause of AKI is fully defined.

Action: Call paediatric critical care and nephrology, stop potassium and nephrotoxins, obtain ECG and urgent repeat venous potassium without delaying treatment of credible ECG-positive hyperkalaemia, and manage through the local paediatric emergency protocol. Support ventilation and arrange kidney replacement therapy when complications do not respond promptly to medical management.

Synopsis

Detect paediatric AKI from creatinine change and urine output, distinguish perfusion, intrinsic and obstructive causes, prescribe fluids from repeated weight-based assessment, stop nephrotoxins and escalate complications promptly.

  • Paediatric AKI is an abrupt fall in kidney function detected by change from the child's baseline, not by an adult creatinine reference range.
  • NICE criteria include creatinine rise of at least 26 micromol/L within 48 hours, at least 50% within 7 days, eGFR fall of at least 25% within 7 days, or urine below 0.5 mL/kg/hour for more than 8 hours.
  • Infant creatinine changes rapidly after birth and initially reflects maternal creatinine; neonatal age, gestation, postnatal day and urine output require neonatal interpretation.
  • Classify causes as reduced renal perfusion, intrinsic renal injury or post-renal obstruction, while recognising that sepsis and critical illness often combine mechanisms.
  • First-line assessment is ABCDE, perfusion, volume status, blood pressure, weight change, measured intake and output, bladder examination and complete medication review.
  • First-line tests are serial creatinine, urea and electrolytes, bicarbonate or blood gas, glucose, calcium, phosphate, FBC and urine dipstick for blood, protein, leucocytes, nitrite and glucose.
  • Stop or withhold avoidable nephrotoxins and renal-haemodynamic medicines during acute hypovolaemia, including NSAIDs, ACE inhibitors, ARBs and unnecessary aminoglycosides; dose essential medicines to current kidney function.
  • For true hypovolaemia, give a cautious isotonic crystalloid bolus under paediatric assessment and reassess pulse, perfusion, pressure, lungs, weight and urine response after each aliquot.
  • Do not give repeated fluid boluses to an oedematous, hypertensive or oliguric child without evidence of fluid responsiveness; overload worsens respiratory and renal outcomes.
  • Once euvolaemic or overloaded, prescribe daily input from insensible needs plus measured urine and other losses, with adjustments for fever, ventilation, drains and ongoing diarrhoea.
  • Loop diuretics do not treat renal injury and are not routine. They may be used for fluid overload while awaiting or during renal replacement therapy if residual urine output exists.
  • Kidney replacement therapy is indicated by refractory hyperkalaemia, acidosis, uraemic complications, pulmonary oedema or fluid overload; do not wait for a fixed creatinine threshold.

Key red flags

Urine output below 0.5 mL/kg/hour for more than 8 hours in a child meets a NICE AKI detection criterion and requires investigation.

A creatinine rise of at least 26 micromol/L within 48 hours or at least 50% within 7 days meets an AKI criterion even when the absolute value appears age-normal.

Hyperkalaemic ECG changes, pulmonary oedema, severe acidosis, uraemic symptoms or refractory fluid overload requires immediate nephrology and critical-care referral.

Haematuria plus proteinuria without UTI or catheter trauma suggests acute nephritis and needs urgent nephrology consideration.

Pyonephrosis requires ultrasound within 6 hours; unexplained AKI or obstruction risk requires urinary ultrasound within 24 hours under NICE NG148.

Stage 3 AKI, no clear cause, inadequate response, transplant status or suspected vasculitis, glomerulonephritis or interstitial nephritis warrants early specialist discussion.

Investigation priorities

01
First-line: serial creatinine and urine outputFirst stepFirst line

Detect AKI and stage change using NICE-approved biochemical and output criteria.

Management branches

DetectionConfirm AKI and severity

Creatinine rises, urine falls or an at-risk child deteriorates.

  1. Compare creatinine with baseline, calculate weight-based urine output and assess paediatric early-warning physiology.
  2. Check renal profile, gas, glucose, calcium, phosphate, urinalysis and a current measured weight.
  3. Stop nephrotoxins, adjust essential medicines and call nephrology immediately for stage 3 disease or life-threatening complications.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG148 acute kidney injuryPaediatric detection criteria, monitoring, ultrasound timing, nephrotoxin, referral and kidney replacement recommendations.
  • NHSGGC acute renal failure guidelineChild-specific causes, fluid accounting, complications and renal escalation.
  • NICE intravenous fluids in childrenWeight-based paediatric assessment, resuscitation, maintenance and reassessment principles.
  • InfoKID acute kidney injuryUK paediatric explanation of causes, treatment, recovery and long-term follow-up.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom